Advertisement
Research Article|Articles in Press

Cardiovascular Disease−Related Emergency Department Visits and Hospitalization among Women with Hypertensive Disorders of Pregnancy

Published:February 28, 2023DOI:https://doi.org/10.1016/j.amepre.2023.01.004

      Introduction

      The risk of developing cardiovascular disease is higher for women who had hypertensive disorders of pregnancy than for women without a history of hypertensive disorders of pregnancy. However, it is unknown whether the emergency department visits and hospitalization differ between women with a history of hypertensive disorders of pregnancy and women without hypertensive disorders of pregnancy. The objective of this study was to characterize and compare cardiovascular disease−related emergency department visits, hospitalization rates, and diagnoses in women with a history of hypertensive disorders of pregnancy with those in women without.

      Method

      This study included participants from the California Teachers Study (N=58,718) with a history of pregnancy and data from 1995 through 2020. Incidence of cardiovascular disease−related emergency department visits and hospitalizations based on linkages with hospital records were modeled using multivariable negative binomial regression. Data were analyzed in 2022.

      Results

      A total of 5% of the women had a history of hypertensive disorders of pregnancy (5.4%, 95% CI=5.2%, 5.6). A total of 31% of women had 1 or more cardiovascular disease−related emergency department visits (30.9%), and 30.1% had 1 or more hospitalizations. The incidence of cardiovascular disease−related emergency department visits (adjusted incident rate ratio=8.96, p<0.001) and hospitalizations (adjusted incident rate ratio=8.88, p<0.001) were significantly higher for women with hypertensive disorders of pregnancy than for those without, adjusting for other related characteristics of the women.

      Conclusions

      History of hypertensive disorders of pregnancy is associated with higher cardiovascular disease−related emergency department visits and hospitalizations. These findings underscore the potential burden on women and the healthcare system of managing complications associated with hypertensive disorders of pregnancy. Evaluating and managing cardiovascular disease risk factors in women with a history of hypertensive disorders of pregnancy is necessary to avoid cardiovascular disease−related emergency department visits and hospitalizations in this group.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Brown HL
        • Warner JJ
        • Gianos E
        • et al.
        Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: a presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists.
        Circulation. 2018; 137: e843-e852https://doi.org/10.1161/CIR.0000000000000582
        • Rich-Edwards JW
        • Fraser A
        • Lawlor DA
        • Catov JM.
        Pregnancy characteristics and women's future cardiovascular health: an underused opportunity to improve women's health?.
        Epidemiol Rev. 2014; 36: 57-70https://doi.org/10.1093/epirev/mxt006
        • Benschop L
        • Duvekot JJ
        • Roeters van Lennep JE
        Future risk of cardiovascular disease risk factors and events in women after a hypertensive disorder of pregnancy.
        Heart. 2019; 105: 1273-1278https://doi.org/10.1136/heartjnl-2018-313453
        • Gunnarsson OS
        • Timpka S.
        Pregnancy complication history in 10-year cardiovascular disease risk prediction: a review of recent evidence.
        Curr Epidemiol Rep. 2019; 6: 321-328https://doi.org/10.1007/s40471-019-00208-2
        • Tooher J
        • Thornton C
        • Makris A
        • Ogle R
        • Korda A
        • Hennessy A.
        All hypertensive disorders of pregnancy increase the risk of future cardiovascular disease.
        Hypertension. 2017; 70: 798-803https://doi.org/10.1161/HYPERTENSIONAHA.117.09246
        • Wu P
        • Haththotuwa R
        • Kwok CS
        • et al.
        Preeclampsia and future cardiovascular health: a systematic review and meta-analysis.
        Circ Cardiovasc Qual Outcomes. 2017; 10e003497https://doi.org/10.1161/CIRCOUTCOMES.116.003497
        • Staff AC
        • Johnsen GM
        • Dechend R
        • Redman CWG.
        Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors.
        J Reprod Immunol. 2014; 101–102: 120-126https://doi.org/10.1016/j.jri.2013.09.001
        • Coutinho T
        • Lamai O
        • Nerenberg K.
        Hypertensive disorders of pregnancy and cardiovascular diseases: current knowledge and future directions.
        Curr Treat Options Cardiovasc Med. 2018; 20: 56https://doi.org/10.1007/s11936-018-0653-8
        • Bushnell C
        • McCullough LD
        • Awad IA
        • et al.
        Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association.
        Stroke. 2014; 45: 1545-1588https://doi.org/10.1161/01.str.0000442009.06663.48
        • Mosca L
        • Benjamin EJ
        • Berra K
        • et al.
        Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association.
        Circulation. 2011; 123: 1243-1262https://doi.org/10.1161/CIR.0b013e31820faaf8
        • Stuart JJ
        • Tanz LJ
        • Cook NR
        • et al.
        Hypertensive disorders of pregnancy and 10-year cardiovascular risk prediction.
        J Am Coll Cardiol. 2018; 72: 1252-1263https://doi.org/10.1016/j.jacc.2018.05.077
        • Lewey J
        • Levine LD
        • Yang L
        • Triebwasser JE
        • Groeneveld PW.
        Patterns of postpartum ambulatory care follow-up care among women with hypertensive disorders of pregnancy.
        J Am Heart Assoc. 2020; 9e016357https://doi.org/10.1161/JAHA.120.016357
      1. Melchiorre K, Thilaganathan B, Giorgione V, Ridder A, Memmo A, Khalil A. Hypertensive disorders of pregnancy and future cardiovascular health. Front Cardiovasc Med.2020;7:59. https://doi.org/10.3389/fcvm.2020.00059.

        • Weissmann-Brenner A
        • Heusler I
        • Manteka R
        • Dulitzky M
        • Baum M.
        Postpartum visits in the gynecological emergency room: how can we improve?.
        BMC Pregnancy Childbirth. 2020; 20: 278https://doi.org/10.1186/s12884-020-02927-7
        • Brousseau EC
        • Danilack V
        • Cai F
        • Matteson K.
        Emergency department visits for postpartum hypertension.
        Hypertens Pregnancy. 2017; 36: 212-216https://doi.org/10.1080/10641955.2017.1299171
        • Bernstein L
        • Allen M
        • Anton-Culver H
        • et al.
        High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).
        Cancer Causes Control. 2002; 13: 625-635https://doi.org/10.1023/a:1019552126105
      2. California Teachers Study. https://www.calteachersstudy.org/. Accessed May 13, 2022.

        • Miller EC
        • Boehme AK
        • Chung NT
        • et al.
        Aspirin reduces long-term stroke risk in women with prior hypertensive disorders of pregnancy.
        Neurology. 2019; 92: e305-e316https://doi.org/10.1212/WNL.0000000000006815
        • Stuart JJ
        • Bairey Merz CN
        • Berga SL
        • et al.
        Maternal recall of hypertensive disorders in pregnancy: a systematic review.
        J Womens Health (Larchmt). 2013; 22: 37-47https://doi.org/10.1089/jwh.2012.3740
      3. California Teachers Study. Past questionnaires. https://www.calteachersstudy.org/past-questionnaires. Accessed May 13, 2022.

        • McCormick N
        • Lacaille D
        • Bhole V
        • Avina-Zubieta JA.
        Validity of myocardial infarction diagnoses in administrative databases: a systematic review.
        PLOS ONE. 2014; 9: e92286https://doi.org/10.1371/journal.pone.0092286
        • Palmsten K
        • Huybrechts KF
        • Kowal MK
        • Mogun H
        Hernández-Díaz S. Validity of maternal and infant outcomes within nationwide Medicaid data.
        Pharmacoepidemiol Drug Saf. 2014; 23: 646-655https://doi.org/10.1002/pds.3627
        • Sigakis MJ
        • Leffert LR
        • Mirzakhani H
        • et al.
        The validity of discharge billing codes reflecting severe maternal morbidity.
        Anesth Analg. 2016; 123: 731-738https://doi.org/10.1213/ANE.0000000000001436
        • Leon LJ
        • McCarthy FP
        • Direk K
        • et al.
        Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records: a CALIBER study.
        Circulation. 2019; 140: 1050-1060https://doi.org/10.1161/CIRCULATIONAHA.118.038080
        • Goldstein SA
        • Pagidipati NJ.
        Hypertensive disorders of pregnancy and heart failure risk.
        Curr Hypertens Rep. 2022; 24: 205-213https://doi.org/10.1007/s11906-022-01189-2
        • Rosenbloom JI
        • Stwalley D
        • Lindley KJ
        • Michael Nelson DM
        • Olsen MA
        • Stout MJ
        Latency of preterm hypertensive disorders of pregnancy and subsequent cardiovascular complications.
        Pregnancy Hypertens. 2020; 21: 139-144https://doi.org/10.1016/j.preghy.2020.05.015
        • Grand'Maison S
        • Pilote L
        • Schlosser K
        • Stewart DJ
        • Okano M
        • Dayan N.
        Clinical features and outcomes of acute coronary syndrome in women with previous pregnancy complications.
        Can J Cardiol. 2017; 33: 1683-1692https://doi.org/10.1016/j.cjca.2017.08.025
        • Umesawa M
        • Kobashi G.
        Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis.
        Hypertens Res. 2017; 40: 213-220https://doi.org/10.1038/hr.2016.126
        • de Jager SCA
        • Meeuwsen JAL
        • van Pijpen FM
        • et al.
        Preeclampsia and coronary plaque erosion: manifestations of endothelial dysfunction resulting in cardiovascular events in women.
        Eur J Pharmacol. 2017; 816: 129-137https://doi.org/10.1016/j.ejphar.2017.09.012
        • Weissgerber TL
        • Turner ST
        • Bailey KR
        • et al.
        Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy.
        Atherosclerosis. 2013; 229: 212-216https://doi.org/10.1016/j.atherosclerosis.2013.04.012
        • Scantlebury DC
        • Kattah AG
        • Weissgerber TL
        • et al.
        Impact of a history of hypertension in pregnancy on later diagnosis of atrial fibrillation.
        J Am Heart Assoc. 2018; 7e007584https://doi.org/10.1161/JAHA.117.007584
        • Muller KE
        • FBA
        Regression and ANOVA: an Integrated Approach Using SAS Software.
        SAS Institute, Cary, NC2002
        • Lacey JV
        • Chung NT
        • Hughes P
        • et al.
        Insights from adopting a data commons approach for large-scale observational cohort studies: the California Teachers Study.
        Cancer Epidemiol Biomarkers Prev. 2020; 29: 777-786https://doi.org/10.1158/1055-9965.EPI-19-0842
      4. Wasserstein RL, Lazar NA. The ASA statement on p-values: context, process, and purpose. In:. The American Statistician: Taylor & Francis. 2016;70(2):129–133. https://doi.org/10.1080/00031305.2016.1154108.

        • Hermes W
        • Tamsma JT
        • Grootendorst DC
        • et al.
        Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up study.
        BMC Pregnancy Childbirth. 2013; 13: 126https://doi.org/10.1186/1471-2393-13-126
        • American College of Obstetricians and Gynecologists’ Presidential Task Force on Pregnancy and Heart Disease and Committee on Practice Bulletins—Obstetrics
        ACOG Practice Bulletin No. 212: Pregnancy and heart disease.
        Obstet Gynecol. 2019; 133: e320-e356https://doi.org/10.1097/AOG.0000000000003243
      5. Mensah GA, Brown DW. An overview of cardiovascular disease burden in the United States. Health Aff (Millwood).2007;26(1):38–48. https://doi.org/10.1377/hlthaff.26.1.38.

        • Brown MA
        • Magee LA
        • Kenny LC
        • et al.
        Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice.
        Hypertension. 2018; 72: 24-43https://doi.org/10.1161/HYPERTENSIONAHA.117.10803
        • Folk DM.
        Hypertensive disorders of pregnancy: overview and current recommendations.
        J Midwifery Womens Health. 2018; 63: 289-300https://doi.org/10.1111/jmwh.12725
        • Hanchate AD
        • Dyer KS
        • Paasche-Orlow MK
        • et al.
        Disparities in emergency department visits among collocated racial/ethnic Medicare enrollees.
        Ann Emerg Med. 2019; 73: 225-235https://doi.org/10.1016/j.annemergmed.2018.09.007
        • Miller EC
        • Zambrano Espinoza MD
        • Huang Y
        • et al.
        Maternal race/ethnicity, hypertension, and risk for stroke during delivery admission.
        J Am Heart Assoc. 2020; 9e014775https://doi.org/10.1161/JAHA.119.014775
        • Zhang X
        • Carabello M
        • Hill T
        • Bell SA
        • Stephenson R
        • Mahajan P.
        Trends of racial/ethnic differences in emergency department care outcomes among adults in the United States from 2005 to 2016.
        Front Med (Lausanne). 2020; 7: 300https://doi.org/10.3389/fmed.2020.00300
        • Ray JG
        • Vermeulen MJ
        • Schull MJ
        • Redelmeier DA.
        Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study.
        Lancet. 2005; 366: 1797-1803https://doi.org/10.1016/S0140-6736(05)67726-4
        • Bokslag A
        • Franssen C
        • Alma LJ
        • et al.
        Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: an observational study.
        PLOS ONE. 2018; 13e0198908https://doi.org/10.1371/journal.pone.0198908
        • Bergen NE
        • Schalekamp-Timmermans S
        • Roos-Hesselink J
        • Roeters van Lennep JER
        • Jaddoe VVW
        • Steegers EAP
        Hypertensive disorders of pregnancy and subsequent maternal cardiovascular health.
        Eur J Epidemiol. 2018; 33: 763-771https://doi.org/10.1007/s10654-018-0400-1
        • White WM
        • Mielke MM
        • Araoz PA
        • et al.
        A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later.
        Am J Obstet Gynecol. 2016; 214 (519.e1–519.e8)https://doi.org/10.1016/j.ajog.2016.02.003
        • Ford ND
        • Cox S
        • Ko JY
        • et al.
        Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017–2019.
        MMWR Morb Mortal Wkly Rep. 2022; 71: 585-591
        • Butwick AJ
        • Druzin ML
        • Shaw GM
        • Guo N.
        Evaluation of US state–level variation in hypertensive disorders of pregnancy.
        JAMA Netw Open. 2020; 3e2018741https://doi.org/10.1001/jamanetworkopen.2020.18741